Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
IACS-6274 With or Without Pembrolizumab for the Treatment of Advanced Solid Tumors - Drug Trials For Money - Paid Clinical Trials

IACS-6274 With or Without Pembrolizumab for the Treatment of Advanced Solid Tumors

IACS-6274 With or Without Pembrolizumab for the Treatment of Advanced Solid Tumors
Conditions:   Advanced Endometrial Carcinoma;   Advanced Head and Neck Squamous Cell Carcinoma;   Advanced Malignant Solid Neoplasm;   Advanced Melanoma;   Advanced Ovarian Clear Cell Adenocarcinoma;   Chondrosarcoma;   Clinical Stage III Cutaneous Melanoma AJCC v8;   Clinical Stage IV Cutaneous Melanoma AJCC v8;   Pathologic Stage III Cutaneous Melanoma AJCC v8;   Pathologic Stage IIIA Cutaneous Melanoma AJCC v8;   Pathologic Stage IIIB Cutaneous Melanoma AJCC v8;   Pathologic Stage IIIC Cutaneous Melanoma AJCC v8;   Pathologic Stage IIID Cutaneous Melanoma AJCC v8;   Pathologic Stage IV Cutaneous Melanoma AJCC v8;   Refractory Endometrial Carcinoma;   Refractory Head and Neck Squamous Cell Carcinoma;   Refractory High Grade Ovarian Serous Adenocarcinoma;   Refractory Melanoma;   Refractory Ovarian Clear Cell Adenocarcinoma;   Stage III Ovarian Cancer AJCC v8;   Stage III Uterine Corpus Cancer AJCC v8;   Stage IIIA Ovarian Cancer AJCC v8;   Stage IIIA Uterine Corpus Cancer AJCC v8;   Stage IIIA1 Ovarian Cancer AJCC v8;   Stage IIIA2 Ovarian Cancer AJCC v8;   Stage IIIB Ovarian Cancer AJCC v8;   Stage IIIB Uterine Corpus Cancer AJCC v8;   Stage IIIC Ovarian Cancer AJCC v8;   Stage IIIC Uterine Corpus Cancer AJCC v8;   Stage IIIC1 Uterine Corpus Cancer AJCC v8;   Stage IIIC2 Uterine Corpus Cancer AJCC v8;   Stage IV Ovarian Cancer AJCC v8;   Stage IV Uterine Corpus Cancer AJCC v8;   Stage IVA Ovarian Cancer AJCC v8;   Stage IVA Uterine Corpus Cancer AJCC v8;   Stage IVB Ovarian Cancer AJCC v8;   Stage IVB Uterine Corpus Cancer AJCC v8
Interventions:   Drug: Glutaminase Inhibitor IPN60090;   Biological: Pembrolizumab
Sponsor:   M.D. Anderson Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 11, 2021 / by / in
Comments